Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Microbiol Resour Announc ; 13(4): e0106123, 2024 Apr 11.
Artículo en Inglés | MEDLINE | ID: mdl-38497622

RESUMEN

Information about the microbiota in marine sediments is important because the microbiota and their activities in sediments affect the surrounding marine environment. To evaluate the microbial diversity, we performed 16S rRNA gene amplicon sequencing on sediment samples from 19 stations in Tsukumo Bay, the northern area of Noto Peninsula, Japan.

2.
Biomacromolecules ; 25(3): 1481-1490, 2024 Mar 11.
Artículo en Inglés | MEDLINE | ID: mdl-38343080

RESUMEN

Developing anticancer agents with negligible cytotoxicity against normal cells while mitigating multidrug resistance and metastasis is challenging. Previously reported cationic polymers have effectively eradicated cancers but are clinically unsuitable due to their limited selectivity. Herein, a series of poly(l-lysine)- and nicotinic acid-based polymers were synthesized using varying amounts of dodecylsuccinic anhydride. Zn-coordinating polymers concealed their cationic charge and enhanced selectivity. These Zn-bound polymers were highly effective against liver and colon cancer cells (HepG2 and Colon 26, respectively) and prevented cancer cell migration. They also displayed potent anticancer activity against drug-resistant cell lines (COR-L23/R): their cationic structure facilitated cancer cell membrane disruption. Compared to these polymers, doxorubicin was less selective and less efficacious against drug-resistant cell lines and was unable to prevent cell migration. These polymers are potential cancer treatment agents, offering a promising solution for mitigating drug resistance and tumor metastasis and representing a novel approach to designing cancer therapeutics.


Asunto(s)
Antineoplásicos , Neoplasias , Humanos , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Doxorrubicina/química , Neoplasias/tratamiento farmacológico , Neoplasias/patología , Polímeros/química , Zinc , Línea Celular Tumoral
3.
Immunotherapy ; 15(16): 1401-1414, 2023 11.
Artículo en Inglés | MEDLINE | ID: mdl-37727966

RESUMEN

Background: Data are limited for clinical outcomes with house dust mite (HDM) allergen immunotherapy beyond 2 years' observation. Materials & methods: A post-marketing drug-use survey assessed the safety and effectiveness of the 300 index of reactivity (IR) HDM tablet during use for up to 4 years in Japan. Results: 538 patients were evaluable for safety and 383 for effectiveness. Most adverse drug reactions (ADRs) occurred early and were local reactions; 5.6% of 249 total events were reported during years 2 to 4 as new ADRs after the interim analysis. The CAP-RAST score was identified as a potential risk factor for ADRs. The proportion of evaluable patients with severe allergic rhinitis symptoms decreased from 46.4% at baseline (n = 317) to 1.0% at 4 years (n = 104). Patients (n = 16) who discontinued 300 IR HDM tablet due to symptomatic improvement had sustained improvement relative to baseline 1 to 2 years later. Conclusion: Long-term use of the 300 IR HDM tablet is safe and effective.


The 300 index of reactivity house dust mite (HDM) sublingual tablet (Actair®) is a treatment option for people with HDM allergy. A Japanese study investigated the safety and effectiveness of the HDM sublingual tablet during its use for up to 4 years. Less than a third of patients (29%) reported adverse effects, mainly itching or irritation in the mouth. The percentage of patients with no allergic rhinitis symptoms increased from 0.3% before treatment to 57.7% after 4 years of use. The percentage of patients who perceived that their allergic rhinitis had improved 'substantially' compared with before treatment increased from 22.3% at 6 months to 73.5% at 4 years. Patients who ended treatment with the HDM sublingual tablet because their symptoms had improved continued to perceive benefit 1 to 2 years later. Clinical Trial Registration: University hospital Medical Information Network (UMIN) Clinical Trials Registry identifier: UMIN000042840.


Asunto(s)
Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Rinitis Alérgica , Inmunoterapia Sublingual , Animales , Humanos , Pyroglyphidae , Japón , Inmunoterapia Sublingual/efectos adversos , Resultado del Tratamiento , Rinitis Alérgica/tratamiento farmacológico , Comprimidos , Antígenos Dermatofagoides/uso terapéutico , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/etiología , Mercadotecnía , Vigilancia de Productos Comercializados , Alérgenos
4.
Histopathology ; 82(3): 466-477, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-36254632

RESUMEN

Microsatellite instability (MSI) is a major carcinogenic pathway with prognostic and predictive implications. The validity of polymerase chain reaction (PCR)-based MSI testing is well established in colorectal cancer; however, the data are limited in non-colorectal gastrointestinal cancers. The aim of this study is to clarify the detailed MSI profiles of non-colorectal gastrointestinal cancers and to investigate the differences from those of colorectal cancers. MSI testing was performed using paired tumour/normal tissues of 123 mismatch repair-deficient cancers detected by immunohistochemistry including 80 non-colorectal cancers (eight oesophagogastric junction (EGJ), 57 gastric and 15 small intestine) and 43 colorectal cancers. Fragment size analysis revealed that the mean nucleotide shifts of five markers (Promega panel) were the highest in the stomach (6.4), followed by colorectum (5.7), small intestine (5.0) and EGJ cancers (mean = 4.0; P = 0.015, versus stomach). All cases showed ≥ 1 nucleotide shift in ≥ 2 markers and were considered as MSI-high. However, when the cut-off was set to ≥ 3 nucleotide shifts in ≥ 2 markers, three EGJ (37.5%), two small intestine (13.3%) and two gastric (3.5%) cancers showed false-negative results. In addition, cases with isolated loss of MSH6 or PMS2 showed smaller nucleotide shifts than those in others. MSI testing is applicable to non-colorectal gastrointestinal cancers; however, a subset can yield false-negative results due to subtle nucleotide shift in multiple markers. Analysis of paired tumour/normal tissues and careful interpretation is necessary to avoid false-negative results and ensure appropriate treatment.


Asunto(s)
Neoplasias Colorrectales , Neoplasias Gastrointestinales , Síndromes Neoplásicos Hereditarios , Humanos , Inestabilidad de Microsatélites , Neoplasias Gastrointestinales/genética , Neoplasias Colorrectales/patología , Nucleótidos , Reparación de la Incompatibilidad de ADN , Repeticiones de Microsatélite
6.
J Infect Chemother ; 28(6): 823-827, 2022 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-35135708

RESUMEN

INTRODUCTION: Hemophagocytic syndrome (HPS) is a rare but potentially fatal complication of viral infections. Epstein-Barr virus (EBV) and cytomegalovirus (CMV) often infect patients receiving TNF-alpha inhibitors (TNF-α inhibitors). While EBV and CMV are well established infections for the development of infectious mononucleosis, coinfection with EBV and CMV is common among immunosuppressed patients and can result in a fatal course. In addition, such viral infections can cause HPS. To the best of our knowledge, we present here the first report of HPS induced by EBV and CMV coinfection during anti-TNFα inhibitor use. CASE REPORT: A 23-year-old man hospitalized with fever, elevated liver enzymes, lymphadenopathy, and hepatosplenomegaly was diagnosed with HPS associated with EBV and CMV coinfection while using adalimumab. No clinical improvement was observed after discontinuation of adalimumab. HPS complicated by EBV and CMV coinfection was finally diagnosed, and immediate administration of ganciclovir and prednisone was considered to have prevented a lethal clinical outcome. CONCLUSION: For cases showing unexplained fever, elevated liver enzymes, and lymphadenopathy while using anti-TNFα inhibitors, screening for EBV and CMV coinfection should be encouraged. In addition, HPS should be considered in patients with EBV and/or CMV infection receiving anti-TNFα inhibitors to facilitate early definitive therapy.


Asunto(s)
Coinfección , Infecciones por Citomegalovirus , Infecciones por Virus de Epstein-Barr , Hepatopatías , Linfadenopatía , Linfohistiocitosis Hemofagocítica , Adalimumab/efectos adversos , Adulto , Coinfección/tratamiento farmacológico , Citomegalovirus , Infecciones por Citomegalovirus/complicaciones , Infecciones por Citomegalovirus/diagnóstico , Infecciones por Citomegalovirus/tratamiento farmacológico , Infecciones por Virus de Epstein-Barr/complicaciones , Infecciones por Virus de Epstein-Barr/diagnóstico , Infecciones por Virus de Epstein-Barr/tratamiento farmacológico , Herpesvirus Humano 4 , Humanos , Linfadenopatía/complicaciones , Linfohistiocitosis Hemofagocítica/complicaciones , Linfohistiocitosis Hemofagocítica/diagnóstico , Linfohistiocitosis Hemofagocítica/tratamiento farmacológico , Masculino , Factor de Necrosis Tumoral alfa , Adulto Joven
7.
J Gen Fam Med ; 23(1): 67, 2022 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-35004116
8.
J Gen Fam Med ; 22(6): 334-340, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-34754711

RESUMEN

BACKGROUND: Population aging requires more physician home visits, and various measures need to be taken to reduce the burden on visiting physicians. However, the incidence and associated factors of burdensome emergency home visits remain unclear. We aimed to reveal the incidences of emergency home visits among cancer and noncancer patients and examine how visiting nurses affect those. METHODS: We performed a prospective cohort study across three clinics in Japan and enrolled the patients receiving home visits within a 3-month study period. We calculated the incidence rates using person-time at risk and conducted a Cox regression in the analysis of risks for emergency home visits. RESULTS: A total of 278 patients were analyzed. The incidences of emergency home visits among the overall, the cancer, and the noncancer home care patients were 1.61, 7.23, and 1.37 per 10 person-months, respectively. The adjusted hazard ratios of a cancer-bearing state and visiting nurse service use were 4.71 (95% confidence interval [CI], 2.60-8.52) and 1.85 (95% CI, 1.77-1.94), respectively. CONCLUSIONS: The incidence of emergency home visits among cancer patients was around five times greater than noncancer patients. Our study did not demonstrate that visiting nurses prevent emergency home visits. Further studies are needed to clarify how visiting nurses reduce physicians' burden.

9.
Immunotherapy ; 13(16): 1333-1343, 2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-34617449

RESUMEN

Background: The efficacy and safety of a house dust mite sublingual tablet (HDM-tab) have been demonstrated in clinical trials, but the findings must be confirmed in real-world use among more widespread patient populations. Materials & methods: A postmarketing drug-use survey is assessing the drug's safety and effectiveness during routine use for up to 4 years. This 2-year interim analysis reports data collected up to March 2020. Results: Of 545 registered outpatients, 526 were evaluable for safety and 371 for effectiveness. Most common adverse drug reactions were local reactions. Mean rhinitis severity score decreased from 2.5 ± 0.8 at baseline to 1.4 ± 0.9, 1.1 ± 0.8 and 1.0 ± 0.8 at 6 months, 1 year and 2 years, respectively. Conclusion: The HDM tab appears to be safe and effective in real-world conditions during 2 years of continuous use. Trial registration number: University hospital Medical Information Network (UMIN) Clinical Trials Registry identifier: UMIN000042840.


Asunto(s)
Antígenos Dermatofagoides/administración & dosificación , Hipersensibilidad/tratamiento farmacológico , Pyroglyphidae , Inmunoterapia Sublingual , Administración Sublingual , Adolescente , Adulto , Anciano , Animales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Comprimidos
11.
Exp Brain Res ; 232(9): 2919-30, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24825825

RESUMEN

We hypothesized that a variety of limb movements in infants, including spontaneous movements and movements during interactions with the environment, can be represented as combinations of limb synergies, which are building blocks for generating coordinated movements of multiple limbs. A decomposition algorithm based on a nonnegative matrix factorization was applied to the discrete data segments taken from continuous data of limb movements in 298 infants (age, 3-4 months). The data were linearly decomposed into bases, which were referred to as synergies. The results showed that approximately 70% of the variance in the velocity profiles of the data segments of the four limbs can be explained by a set of five simple synergies that represent single-limb movements and the synchronous movement of all limbs. The present method showed that the complex properties of limb movements can be represented as combinations of synergies. Furthermore, comparisons of movement patterns across different age groups showed that in older infants, the contribution ratios of each synergy were different between spontaneous movements and movements during playing with a toy, whereas in younger infants, there were no differences in the contribution ratios between the different movement conditions. These results demonstrate that decomposition into limb synergies is useful for determining the spatiotemporal properties of interlimb coordination during spontaneous movements and task-constrained movements in infants.


Asunto(s)
Desarrollo Infantil/fisiología , Extremidades/fisiología , Movimiento/fisiología , Factores de Edad , Algoritmos , Análisis de Varianza , Análisis por Conglomerados , Extremidades/inervación , Femenino , Humanos , Lactante , Masculino , Movimiento (Física) , Desempeño Psicomotor , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...